Proton MR spectroscopy with metabolite-nulling reveals elevated macromolecules in acute multiple sclerosis

Brain

Volumn 124, Issue 5, 2001, Pages 953-961

  Mader, I ^a   Seeger, U ^a   Weissert, R ^a   Klose, U ^a   Naegele, T ^a   Melms, A ^a   Grodd, W ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Absolute quantitation; Lipids; Macromolecules; Multiple sclerosis; NMR spectroscopy

Indexed keywords

ALANINE; CHOLINE; CREATINE; INOSITOL; ISOLEUCINE; LEUCINE; LIPID; MYELIN BASIC PROTEIN; N ACETYLASPARTIC ACID; POLYPEPTIDE; PROTEOLIPID PROTEIN; THREONINE; VALINE;

ACUTE DISEASE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; IMAGE ANALYSIS; MACROMOLECULE; MALE; METABOLITE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0035011595     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/124.5.953     Document Type: Article

References (40)

1. Auer P, Then Bergh F, Kraft E, Trenkwalder C, Holsboer F. Alterations in brain metabolism after high-dose glucocorticoid therapy: a proton magnetic resonance spectroscopy study. In: Proceedings of the 5th Scientific Meeting and Exhibition of the ISMRM; 1997 Apr 12-18; Vancouver, Canada. Berkeley (CA): International Society for Magnetic Resonance in Medicine; 1997. p. 407.
2. Behar KL, Ogino T. Characterization of macromolecule resonances in the 1H NMR spectrum of rat brain. Magn Reson Med 1993; 30: 38-44.
3. Behar KL, Rothman DL, Spencer DD, Petroff OA. Analysis of macromolecule resonances in 1H NMR spectra of human brain. Magn Reson Med 1994; 32: 294-302.
4. Bhakoo KK, Styles P. N-acetyl-aspartate: in-vitro expression in oligodendrocytes; implications for proton-MRS signal in vivo. In: Proceedings of the 8th Scientific Meeting and Exhibition of the ISMRM; 2000 Apr 1-7; Denver (CO), USA. Berkeley (CA): International Society for Magnetic Resonance in Medicine; 2000. p. 567.
5. Bitsch A, Bruhn H, Vougioukas V, Stringaris A, Lassmann H, Frahm J, et al. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol 1999; 20: 1619-27.
6. Brex PA, Gomez-Anson B, Parker GJ, Molyneux PD, Miszkiel KA, Barker GJ, et al. Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis. J Neurol Sci 1999; 166: 16-22.
7. Brück W, Bitsch A, Kolenda H, Brück Y, Stiefel M, Lassmann H. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997; 42: 783-93.
8. Bruhn H, Frahm J, Merboldt KD, Hanicke W, Hanefeld F, Christen HJ, et al. Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo. Ann Neurol 1992; 32: 140-50.
9. Callies R, Sri-Pathmanathan RM, Ferguson DY, Brindle KM. The appearance of neutral lipid signals in the 1H NMR spectra of a myeloma cell line correlates with the induced formation of cytoplasmic lipid droplets. Magn Reson Med 1993; 29: 546-50.
10. Davie CA, Hawkins CP, Barker GJ, Brennan A, Tofts PS, Miller DH, et al. Detection of myelin breakdown products by proton magnetic resonance spectroscopy [letter]. Lancet 1993; 341: 630-1.
11. Davie CA, Hawkins CP, Barker GJ, Brennan A, Tofts PS, Miller DH, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994; 117: 49-58.
12. 1H MRS of human brain tumors. In: Proceedings of the 3rd Scientific Meeting and Exhibition of the SMR; 1995 Aug 19-25; Nice, France. Berkeley (CA): International Society for Magnetic Resonance in Medicine; 1995. p. 1705.
13. Hwang JH, Graham GD, Behar KL, Alger JR, Prichard JW, Rothman DL. Short echo time proton magnetic resonance spectroscopic imaging of macromolecule and metabolite signal intensities in the human brain. Magn Reson Med 1996; 35: 633-9.
14. Katz D, Taubenberger JK, Cannella B, McFarlin DE, Raine CS, McFarland HF. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 1993; 34: 661-9.
15. Khiat A, Bard C, Lacroix A, Rousseau J, Boulanger Y. Brain metabolic alterations in Gushing's syndrome as monitored by proton magnetic resonance spectroscopy. NMR Biomed 1999; 12: 357-63.
16. Koopmans RA, Li DK, Zhu G, Allen PS, Penn A, Paty DW. Magnetic resonance spectroscopy of multiple sclerosis: in-vivo detection of myelin breakdown products [letter]. Lancet 1993; 341: 631-2.
17. Kornek B, Storch MK, Weissert R, Wallstroem R, Stefferl A, Olsson T, et al. Multiple sclerosis and chronic autoimmune encephalomyelitis. A comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 2000; 157: 267-76.
18. Larsson HB, Christiansen P, Jensen M, Frederiksen J, Heltberg A, Olesen J, et al. Localized in vivo proton spectroscopy in the brain of patients with multiple sclerosis. Magn Reson Med 1991; 22: 23-31.
19. Lassmann H. Neuropathology in multiple sclerosis: new concepts. [Review], Mult Scler 1998; 4: 93-8.
20. Lees MB, Brostoff SW. Proteins of myelin. In: Morell P, editor. Myelin. 2nd ed. New York: Plenum Press; 1984. p. 197-224.
21. Lucchinetti CF, Brück W, Rodriguez M, Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. [Review]. Brain Pathol 1996; 6: 259-74.
22. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 1999; 122: 2279-95.
23. Miller DH, Grossman RI, Reingold SC, McFarland HF. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. [Review]. Brain 1998; 121: 3-24.
24. Narayana PA, Wolinsky JS, Jackson EF, McCarthy M. Proton MR spectroscopy of gadolinium-enhanced multiple sclerosis plaques. J Magn Reson Imaging 1992; 2: 263-70.
25. Narayana PA, Doyle TJ, Lai D, Wolinsky JS. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann Neurol 1998; 43: 56-71.
26. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
27. Prineas JW, Barnard RO, Kwon EE, Sharer LR, Cho ES. Multiple sclerosis: remyelination of nascent lesions. Ann Neurol 1993; 33: 137-51.
28. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672-9.
29. Roser W, Mader I, Hagberg G, Seelig J, Kappos L, Radue E.W, et al. Metabolic changes of primary Gd-enhancing MS-plaques during medical treatment. In: Proceedings of the 4th Scientific Meeting and Exhibition of the ISMRM; 1996 Apr 27-May 18; New York (NY), USA. Berkeley (CA): International Society for Magnetic Resonance in Medicine; 1996. p. 940.
30. Sarchielli P, Presciutti O, Tarducci R, Gobbi G, Alberti A, Pelliccioli GP, et al. IH-MRS in patients with multiple sclerosis undergoing treatment with interferon beta-la: results of a preliminary study. J Neurol Neurosurg Psychiatry 1998; 64: 204-12.
31. Sarchielli P, Presciutti O, Pelliccioli GP, Tarducci R, Gobbi G, Chiarini P, et al. Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients. Brain 1999; 122: 513-21.
32. Saunders DE, Howe FA, van den Boogaart A, Griffiths JR, Brown MM. Discrimination of metabolite from lipid and macromolecule resonances in cerebral infarction in humans using short echo proton spectroscopy. J Magn Reson Imaging 1997; 7: 1116-21.
33. Schick F, Eismann B, Jung WI, Bongers H, Bunse M, Lutz O. Comparison of localized proton NMR signals of skeletal muscle and fat tissue in vivo: two lipid compartments in muscle tissue. Magn Reson Med 1993; 29: 158-67.
34. Seeger U, Klose U, Lutz O, Grodd W. Elimination of residual lipid contamination in single volume proton MR spectra of human brain. Magn Reson Imaging 1999; 17: 1219-26.
35. 1H spectra of human brain. In: Proceedings of the 8th Scientific Meeting and Exhibition of the ISMRM; 2000 Apr 1-7; Denver (CO), USA. Berkeley (CA): International Society for Magnetic Resonance in Medicine; 2000. p. 1840.
36. Sijens PE, Oudkerk M, van Dijk P, Levendag PC, Vecht CJ. 1H MR spectroscopy monitoring of changes in choline peak area and line shape after Gd-contrast administration. Magn Reson Imaging 1998; 16: 1273-80.
37. Smith KJ, Kwock L, Castillo M. Effects of contrast material on single-volume proton MR spectroscopy. AJNR Am J Neuroradiol 2000; 21: 1084-9.
38. Taylor JS, Reddick WE, Kingsley PB, Ogg RJ. Proton MRS after gadolinium contrast agent. In: Proceedings of the 3rd Scientific Meeting and Exhibition of the SMR; 1995 Aug 19-25; Nice, France. Berkeley (CA): International Society for Magnetic Resonance in Medicine; 1995. p. 1854.
39. Wolinsky JS, Narayana PA, Fenstermacher MJ. Proton magnetic resonance spectroscopy in multiple sclerosis. Neurology 1990; 40: 1764-9.
40. Wolswijk G. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis. Brain 2000; 123: 105-15.